125 filings
8-K
APTO
Aptose Biosciences Inc
6 May 24
Regulation FD Disclosure
4:45pm
8-K
APTO
Aptose Biosciences Inc
1 May 24
Entry into a Material Definitive Agreement
4:30pm
8-K
APTO
Aptose Biosciences Inc
26 Apr 24
Entry into a Material Definitive Agreement
7:30am
8-K
APTO
Aptose Biosciences Inc
5 Apr 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:05pm
8-K
APTO
Aptose Biosciences Inc
26 Mar 24
Aptose Reports Results for the Fourth Quarter and Full Year 2023
4:04pm
8-K
qo7lh
18 Mar 24
Regulation FD Disclosure
4:45pm
8-K
ltyv9y6bkl lj2
1 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
oyqoam 2me7
31 Jan 24
Regulation FD Disclosure
4:02pm
8-K
9pvys5h338
29 Jan 24
Entry into a Material Definitive Agreement
9:44pm
8-K
t1kry15669
26 Jan 24
Aptose Announces Pricing of $8.4 Million Public Offering and a Concurrent $4 Million Private Placement with Hanmi Pharmaceutical
8:00am
8-K
a4sybvbp8geveb
11 Dec 23
Aptose Tuspetinib Clinical Data Featured in Oral Presentation at the 2023 ASH Annual Meeting
6:30am
8-K
lhxggvp4otup
30 Nov 23
Aptose Appoints Fletcher Payne Chief Business Officer, Expanding his Executive Role
5:28pm
8-K
f4k1nv6053s9xv9
9 Nov 23
Aptose Reports Results for the Third Quarter 2023
4:15pm
8-K
d1adxs48qgq8f7a
2 Nov 23
Aptose Tuspetinib Clinical Data Selected for Oral Presentation at the 2023 ASH Annual Meeting
9:15am
8-K
xzbky2oow m3lyl26cfr
30 Oct 23
Aptose Presents Highlights from Clinical Update Webcast Featuring Latest Available Data on AML Drug Tuspetinib
9:20am
8-K
v1hxa0o1pcihu2u
26 Oct 23
Regulation FD Disclosure
10:12am
8-K
uv41v0
23 Oct 23
Aptose to Hold Clinical Update and KOL Data Review of AML Drug Tuspetinib on Monday, October 30th
8:00am
8-K
1izst7rlz4m6hn26qvcg
16 Oct 23
Aptose Clinical and Preclinical Data to be Presented at European School of Haematology (ESH) 6th International Conference
8:00am
8-K
i1jkguy4pabjvw
18 Sep 23
Aptose to Present at the Cantor Global Healthcare Conference
8:00am
8-K
638t4h8 2q8fif5imyo
12 Sep 23
Entry into a Material Definitive Agreement
4:30pm